Larry M. Lopez

1.6k total citations
61 papers, 1.2k citations indexed

About

Larry M. Lopez is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Larry M. Lopez has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 16 papers in Pharmacology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Larry M. Lopez's work include Blood Pressure and Hypertension Studies (16 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Analytical Methods in Pharmaceuticals (9 papers). Larry M. Lopez is often cited by papers focused on Blood Pressure and Hypertension Studies (16 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Analytical Methods in Pharmaceuticals (9 papers). Larry M. Lopez collaborates with scholars based in United States and Australia. Larry M. Lopez's co-authors include Jawahar L. Mehta, Thomas J. Wargovich, Stefan M. Lupkiewicz, Jessica Robinson, Mario Ariet, Carl J. Pepine, Kevin Coy, Liying Chen, Charles R. Lambert and James R. Taylor and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

Larry M. Lopez

61 papers receiving 1.1k citations

Peers

Larry M. Lopez

CCM

SURGE

PHYSI

EDM

Stewart Mann New Zealand

Knud Landmark Norway

Ahuva Golik Israel

L E Ramsay United Kingdom

E Ambrosioni Italy

H. Wesseling Netherlands

Charles Swartz United States

LE Ramsay United Kingdom

C. Venkata S. Ram United States

José Pablo Werba Italy

Stewart Mann New Zealand

Larry M. Lopez

1.0k ×1.9

CCM

515 ×1.9

SURGE

131 ×0.8

PHYSI

78 ×0.5

164 ×1.5

EDM

Citations per year, relative to Larry M. Lopez Larry M. Lopez (= 1×) peers Stewart Mann

Countries citing papers authored by Larry M. Lopez

Since Specialization

Citations

This map shows the geographic impact of Larry M. Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry M. Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry M. Lopez more than expected).

Fields of papers citing papers by Larry M. Lopez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry M. Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry M. Lopez. The network helps show where Larry M. Lopez may publish in the future.

Co-authorship network of co-authors of Larry M. Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Larry M. Lopez. A scholar is included among the top collaborators of Larry M. Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry M. Lopez. Larry M. Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dobesh, Paul P., Ann K. Wittkowsky, Zachary A. Stacy, et al.. (2009). Key Articles and Guidelines for the Prevention of Venous Thromboembolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(4). 410–458. 15 indexed citations

Ried, L. Douglas, et al.. (2006). Increased Cardiovascular Risk with Second-Generation Antipsychotic Agent Switches. Journal of the American Pharmacists Association. 46(4). 491–501. 5 indexed citations

Lopez, Larry M.. (2005). Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor. Journal of the American Pharmacists Association. 45(4). 503–513. 10 indexed citations

Lopez, Larry M.. (2001). Low‐Molecular‐Weight Heparins Are Essentially the Same for Treatment and Prevention of Venous Thromboembolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(6P2). 56S–61S; discussion 71S. 13 indexed citations

Rutledge, David R., Alireza Abadi, & Larry M. Lopez. (1994). Liquid chromatographic determination of celiprolol, diltiazem, desmethyldiltiazem and deacetyldiltiazem in plasma using a short alkyl chain silanol deactivated column. Journal of Pharmaceutical and Biomedical Analysis. 12(1). 135–140. 4 indexed citations

Mehta, Jawahar L., et al.. (1994). Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. The American Journal of Cardiology. 74(9). 901–905. 86 indexed citations

Mehta, Jawahar L., Larry M. Lopez, N. D. Vlachakis, et al.. (1993). Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension. American Heart Journal. 125(6). 1704–1710. 23 indexed citations

Rutledge, David R., et al.. (1993). High-performance liquid chromatographic determination of diltiazem and two of its metabolites in plasma using a short alkyl chain silanol deactivated column. Journal of Chromatography B Biomedical Sciences and Applications. 615(1). 111–116. 9 indexed citations

Lopez, Larry M., et al.. (1991). Felodipine: A New Dihydropyridine Calcium-Channel Antagonist. DICP. 25(11). 1193–1206. 9 indexed citations

10.

Lopez, Larry M., et al.. (1990). Nitrendipine: A New Dihydropyridine Calcium-Channel Antagonist for the Treatment of Hypertension. DICP. 24(2). 167–175. 11 indexed citations

11.

Lopez, Larry M., et al.. (1990). Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus. The American Journal of Cardiology. 66(17). 1269–1271. 24 indexed citations

12.

Schaefer, Hans, Hildegard Spahn, Larry M. Lopez, & Hartmut Derendorf. (1990). Simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization using reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 527(2). 351–359. 16 indexed citations

13.

Stein, Gerald H., et al.. (1990). Long-Term Lipid Profiles with Isradipine and Hydrochlorothiazide Treatment in Elderly Hypertensive Patients. Journal of Cardiovascular Pharmacology. 15(Supplement). S90–S92. 5 indexed citations

14.

Mehta, Jawahar L., Michael J. Malloy, Daniel Lawson, & Larry M. Lopez. (1989). Circadian variation in platelet alpha2-adrenoceptor affinity in normal subjects. The American Journal of Cardiology. 63(13). 1002–1005. 5 indexed citations

15.

Williams, Lisa L., et al.. (1988). Plasma Lipid Profiles and Antihypertensive Agents: Effects of Lisinopril, Enalapril, Nitrendipine, Hydralazine, and Hydrochlorothiazide. Drug Intelligence & Clinical Pharmacy. 22(7-8). 546–550. 10 indexed citations

16.

Mehta, Jawahar L., et al.. (1988). Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension. The American Journal of Cardiology. 61(10). 803–806. 8 indexed citations

17.

Lopez, Larry M., et al.. (1987). Effect of New Vacutainer Blood Collection Tubes on Plasma Lidocaine Concentrations. Therapeutic Drug Monitoring. 9(4). 439–442. 1 indexed citations

18.

Mehta, J, Larry M. Lopez, Prakash Deedwania, et al.. (1987). Similar efficacy of nitrendipine in young and elderly hypertensive patients. The American Journal of Cardiology. 60(13). 1096–1100. 6 indexed citations

19.

Parish, Roy C., et al.. (1987). Serum Lidocaine Concentrations Following Application to the Oropharynx. Therapeutic Drug Monitoring. 9(3). 292–297. 3 indexed citations

20.

Lopez, Larry M., et al.. (1984). Inadequacy of FDA Dosing Guidelines for Intravenous Theophylline. Drug Intelligence & Clinical Pharmacy. 18(12). 987–991. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact